Stephen Yarwood

Dr. Stephen Yarwood

Heriot Watt University
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2003 in Experimental Cell Research
Verified
Journal Article
Closed access
MDMatthew J Dalby
Matthew J Dalby
MRMathis O Riehle
Mathis O Riehle
Stephen YarwoodStephen Yarwood
Stephen Yarwood
CWChris D.W Wilkinson
Chris D.W Wilkinson
ACAdam S.G Curtis
Adam S.G Curtis

1 December 2002 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
AMAngela McCahill
Angela McCahill
JWJim Warwicker
Jim Warwicker
GBGraeme B. Bolger
Graeme B. Bolger
MHMiles Houslay
Miles Houslay
Stephen YarwoodStephen Yarwood
Stephen Yarwood

1 May 2002 in Experimental Cell Research
Verified
Journal Article
Closed access
MDMatthew J. Dalby
Matthew J. Dalby
Stephen YarwoodStephen Yarwood
Stephen Yarwood
MRMathis O. Riehle
Mathis O. Riehle
HJHeather J.H. Johnstone
Heather J.H. Johnstone
SAStanley Affrossman
Stanley Affrossman
ACAdam S.G. Curtis
Adam S.G. Curtis

1 May 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Stephen YarwoodStephen Yarwood
Stephen Yarwood
MSMichael R. Steele
Michael R. Steele
GSGrant Scotland
Grant Scotland
MHMiles Houslay
Miles Houslay
GBGraeme B. Bolger
Graeme B. Bolger
The WD-repeat protein receptor for activated C-kinase (RACK1) was identified by its interaction with the cyclic AMP-specific phosphodiesterase (PDE4) isoform PDE4D5 in a yeast two-hybrid screen. The interaction was confirmed by co-immunoprecipitation of native RACK1 and PDE4D5 from COS7, HEK293, 3T3-F442A, and SK-N-SH cell lines. The interaction was unaffected by stimulation of the cells with the phorbol ester phorbol 2-myristate 3-acetate. PDE4D5 did not interact with two other WD-repeat proteins, β’-coatomer protein and Gsβ, in two-hybrid tests. RACK1 did not interact with other PDE4D isoforms or with known PDE4A, PDE4B, and PDE4C isoforms. PDE4D5 and RACK1 interacted with high affinity (K a approximately 7 pm) when they were expressed and purified from Escherichia coli, demonstrating that the interaction does not require intermediate proteins. The binding of the E. coli-expressed proteins did not alter the kinetics of cAMP hydrolysis by PDE4D5 but caused a 3–4-fold change in its sensitivity to inhibition by the PDE4 selective inhibitor rolipram. The subcellular distributions of RACK1 and PDE4D5 were extremely similar, with the major amount of both proteins (70%) in the high speed supernatant (S2) fraction. Analysis of constructs with specific deletions or single amino acid mutations in PDE4D5 demonstrated that a small cluster of amino acids in the unique amino-terminal region of PDE4D5 was necessary for its interaction with RACK1. We suggest that RACK1 may act as a scaffold protein to recruit PDE4D5 and other proteins into a signaling complex.

15 February 1999 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
RHRalf Hoffmann
Ralf Hoffmann
GBGeorge Baillie
George Baillie
SMSimon J. MacKenzie
Simon J. MacKenzie
Stephen YarwoodStephen Yarwood
Stephen Yarwood
MHMiles Houslay
Miles Houslay
The extracellular receptor stimulated kinase ERK2 (p42MAPK)‐phosphorylated human cAMP‐specific phosphodiesterase PDE4D3 at Ser579 and profoundly reduced (∼75%) its activity. These effects could be reversed by the action of protein phosphatase PP1. The inhibitory state of PDE4D3, engendered by ERK2 phosphorylation, was mimicked by the Ser579→Asp mutant form of PDE4D3. In COS1 cells transfected to express PDE4D3, challenge with epidermal growth factor (EGF) caused the phosphorylation and inhibition of PDE4D3. This effect was blocked by the MEK inhibitor PD98059 and was not apparent using the Ser579→Ala mutant form of PDE4D3. Challenge of HEK293 and F442A cells with EGF led to the PD98059‐ablatable inhibition of endogenous PDE4D3 and PDE4D5 activities. EGF challenge of COS1 cells transfected to express PDE4D3 increased cAMP levels through a process ablated by PD98059. The activity of the Ser579→Asp mutant form of PDE4D3 was increased by PKA phosphorylation. The transient form of the EGF‐induced inhibition of PDE4D3 is thus suggested to be due to feedback regulation by PKA causing the ablation of the ERK2‐induced inhibition of PDE4D3. We identify a novel means of cross‐talk between the cAMP and ERK signalling pathways whereby cell stimuli that lead to ERK2 activation may modulate cAMP signalling.

1 March 2004 in Journal of Controlled Release
Verified
Journal Article
Closed access
AGAjay Kumar Gupta
Ajay Kumar Gupta
MGMona Gupta
Mona Gupta
Stephen YarwoodStephen Yarwood
Stephen Yarwood
ACAdam S.G. Curtis
Adam S.G. Curtis